AAAAAA

   
Results: 1-14 |
Results: 14
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
Authors: Brada, M Hoang-Xuan, K Rampling, R Dietrich, PY Dirix, LY Macdonald, D Heimans, JJ Zonnenberg, BA Bravo-Marques, JM Henriksson, R Stupp, R Yue, N Bruner, J Dugan, M Rao, S Zaknoen, S
Citation: M. Brada et al., Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse, ANN ONCOL, 12(2), 2001, pp. 259-266
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study
Authors: Eiermann, W Paepke, S Appfelstaedt, J Llombart-Cussac, A Eremin, J Vinholes, J Mauriac, L Ellis, M Lassus, M Chaudri-Ross, HA Dugan, M Borgs, M Semiglazov, V
Citation: W. Eiermann et al., Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study, ANN ONCOL, 12(11), 2001, pp. 1527-1532
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: Evidence from a phase III randomized trial
Authors: Ellis, MJ Coop, A Singh, B Mauriac, L Llombert-Cussac, A Janicke, F Miller, WR Evans, DB Dugan, M Brady, C Quebe-Fehling, E Borgs, M
Citation: Mj. Ellis et al., Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: Evidence from a phase III randomized trial, J CL ONCOL, 19(18), 2001, pp. 3808-3816
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: Results of a phase III study of the international letrozole breast cancer group
Authors: Mouridsen, H Gershanovich, M Sun, Y Perez-Carrion, R Boni, C Monnier, A Apffelstaedt, J Smith, R Sleeboom, HP Janicke, F Pluzanska, A Dank, M Becquart, D Bapsy, PP Salminen, E Snyder, R Lassus, M Verbeek, JA Staffler, B Chaudri-Ross, HA Dugan, M
Citation: H. Mouridsen et al., Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: Results of a phase III study of the international letrozole breast cancer group, J CL ONCOL, 19(10), 2001, pp. 2596-2606
Shirley McLaren 1930-1999
Authors: Dugan, M
Citation: M. Dugan, Shirley McLaren 1930-1999, OVERLAND, 159, 2000, pp. 4-4
Dirty work
Authors: Dugan, M
Citation: M. Dugan, Dirty work, FORBES, 165(2), 2000, pp. 24-24
Absorption, metabolism, and excretion of C-14-temozolomide following oral administration to patients with advanced cancer
Authors: Baker, SD Wirth, M Statkevich, P Reidenberg, P Alton, K Sartorius, SE Dugan, M Cutler, D Batra, V Grochow, LB Donehower, RC Rowinsky, EK
Citation: Sd. Baker et al., Absorption, metabolism, and excretion of C-14-temozolomide following oral administration to patients with advanced cancer, CLIN CANC R, 5(2), 1999, pp. 309-317
Characterization and partial purification of CD34(+) progenitor cell ecto-phosphatidic acid phosphohydrolase
Authors: Harvey, KA Siddiqui, RA Reeves, M Kovala, T Dugan, M Akard, LP English, D
Citation: Ka. Harvey et al., Characterization and partial purification of CD34(+) progenitor cell ecto-phosphatidic acid phosphohydrolase, BIOC MOL B, 47(1), 1999, pp. 9-23
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse
Authors: Yung, WKA Prados, MD Yaya-Tur, R Rosenfeld, SS Brada, M Friedman, HS Albright, R Olson, J Chang, SM O'Neill, AM Friedman, AH Bruner, J Yue, N Dugan, M Zaknoen, S Levin, VA
Citation: Wka. Yung et al., Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse, J CL ONCOL, 17(9), 1999, pp. 2762-2771
Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies
Authors: Hammond, LA Eckardt, JR Baker, SD Eckhardt, SG Dugan, M Forral, K Reidenberg, P Statkevich, P Weiss, GR Rinaldi, DA Von Hoff, DD Rowinsky, EK
Citation: La. Hammond et al., Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies, J CL ONCOL, 17(8), 1999, pp. 2604-2613
Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells
Authors: Rizzo, MT Regazzi, E Garau, D Akard, L Dugan, M Boswell, HS Rizzoli, V Carlo-Stella, C
Citation: Mt. Rizzo et al., Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells, CANCER RES, 59(19), 1999, pp. 5047-5053
Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies
Authors: Brada, M Judson, I Beale, P Moore, S Reidenberg, P Statkevich, P Dugan, M Batra, V Cutler, D
Citation: M. Brada et al., Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies, BR J CANC, 81(6), 1999, pp. 1022-1030
Anxiolytic effects of the neuroactive steroid pregnanolone (3 alpha-OH-5 beta-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum
Authors: Bitran, D Dugan, M Renda, P Ellis, R Foley, M
Citation: D. Bitran et al., Anxiolytic effects of the neuroactive steroid pregnanolone (3 alpha-OH-5 beta-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum, BRAIN RES, 850(1-2), 1999, pp. 217-224
DNA mismatch repair and O-6-alkylguanine-DNA alkyltransferase analysis andresponse to temodal in newly diagnosed malignant glioma
Authors: Friedman, HS McLendon, RE Kerby, T Dugan, M Bigner, SH Henry, AJ Ashley, DM Krischer, J Lovell, S Rasheed, K Marchev, F Seman, AJ Cokgor, I Rich, J Stewart, E Colvin, OM Provenzale, JM Bigner, DD Haglund, MM Friedman, AH Modrich, PL
Citation: Hs. Friedman et al., DNA mismatch repair and O-6-alkylguanine-DNA alkyltransferase analysis andresponse to temodal in newly diagnosed malignant glioma, J CL ONCOL, 16(12), 1998, pp. 3851-3857
Risultati: 1-14 |